Read Time:1 Minute, 1 Second
News On Japan via Mainichi — Oct 14
Hisashi Moriguchi, a Japanese researcher who had said he implemented the world’s first clinical trial using a trailblazing stem cell technology, admitted Saturday most of what he claimed in an academic conference presentation about the procedure was false.
At a news conference in New York, Moriguchi said, “While the treatment was implemented, it was only one procedure. At the end of the day, I lied.”He earlier said treatment using induced pluripotent stem cells was conducted on a total of six people, including the first case on a man with a failing heart in February this year. He also corrected the timing of the trial to June last year.
He said he was present during the procedure allegedly undertaken in the United States and showed his passport record to reporters.
Massachusetts General Hospital in Boston, where he claimed that the trial was conducted, said Friday there are no records of him having undertaken the procedure or of applying for approval to carry it out.
iPS細胞(人工多能性幹細胞)を使った臨床応用について、虚偽の発表をした森口尚史氏は、13日、滞在先のアメリカ・ニューヨークで会見し、6例行ったと主張した手術のうち、5例についてはうそだったと認めた。